Blog
RSS FeedPosted by Michael Wonder on 15 Mar 2018
Pharmacare and the chaotic world of Canadian drug prices
15 March 2018 - The cost of a life-saving drug to treat cystinosis — a rare disease affecting probably 100 ...
Posted by Michael Wonder on 13 Mar 2018
Price and clinical factors impact Canadian orphan drug recommendation rates
11 March 2018 - Canada’s Common Drug Review (CDR), which provides recommendations on public payer reimbursement for all non-oncology drugs, ...
Posted by Michael Wonder on 13 Mar 2018
Canadian families stunned by 3,000% increase in price of life-saving drug
12 March 2018 - Drug for patients with cystinosis being replaced by new form with same active ingredient. ...
Posted by Michael Wonder on 08 Mar 2018
CADTH Common Drug Review will accept submissions up to six months pre-Notice of Compliance
8 March 2018 - Operational change can help reduce the time between regulatory approval and reimbursement recommendations for prescription drugs ...
Posted by Michael Wonder on 06 Mar 2018
Access to new drugs for rare disorders in Canada
2 March 2018 - McMillan and Campbell believe that Canada needs a regulatory framework for the introduction of orphan drugs ...
Posted by Michael Wonder on 01 Mar 2018
Ontario family of toddler with rare disorder seeks funding for expensive drug
27 February 2018 - A family in Windsor, Ontario says they are being forced to choose between spending a fortune ...
Posted by Michael Wonder on 28 Feb 2018
Affordable Pharmacare the goal of study launched in federal budget
28 February 2018 - Advisory panel tasked with bringing relief to Canadians who pay some of the highest prices for prescription ...
Posted by Michael Wonder on 28 Feb 2018
Pharmacare won't be free for all Canadians, Bill Morneau says
28 February 2018 - Finance minister hints 'fiscally responsible' plan won't be universal. ...
Posted by Michael Wonder on 27 Feb 2018
Nova Scotia sets up program to help pay for take-home cancer drugs
27 February 2018 - Patient medication costs are now limited to 4% of a family’s net income under new program. ...
Posted by Michael Wonder on 27 Feb 2018
Sobi’s Orfadin (nitisinone) receives positive reimbursement recommendation for the treatment of HT-1 from CADTH Canadian Drug Expert Committee
27 February 2018 - Sobi announced today that the CADTH Canadian Drug Expert Committee has issued a conditional positive reimbursement ...
Posted by Michael Wonder on 19 Feb 2018
New Patented Medicine Prices Review Board Chairperson announced
17 February 2018 - Dr. Mitchell Levine appointed as Chairperson of the Patented Medicine Prices Review Board. ...
Posted by Michael Wonder on 19 Feb 2018
Medication for rare soft-bone disease to be covered by public drug plans in Canada
15 February 2018 - One of the most expensive medications in the world is about to be covered by public ...
Posted by Michael Wonder on 16 Feb 2018
Quebec and New Brunswick become first provinces to provide public funding of Ibrance for the first-line treatment of metastatic breast cancer
15 February 2018 - Since Ibrance received Health Canada marketing authorisation in March 2016, Canadian women living with metastatic breast cancer ...
Posted by Michael Wonder on 15 Feb 2018
Canadian patient groups call on Federal Health Minister to halt the process examining proposed amendments to the Patented Medicine Regulations pending constructive consultations
15 February 2018 - Patient feedback has not been considered – groups seek meaningful dialogue with Government and drug manufactures ...
Posted by Michael Wonder on 13 Feb 2018
Almost 1 million Canadians give up food, heat to afford prescriptions: study
13 February 2018 - 968,000 people skimped on necessities to pay for their medicine in 2016, researchers find. ...